trending Market Intelligence /marketintelligence/en/news-insights/trending/iyre6pi5tfeu-riudkcqow2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Canada's Evitrade reaches definitive deal to buy hemp extraction company

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Canada's Evitrade reaches definitive deal to buy hemp extraction company

Evitrade Health Systems Corp. signed a binding letter of intent as it reached a definitive deal to acquire Hemp Extraction Technology Corp.

The Canadian healthcare technology company had signed a nonbinding letter of intent in August to buy HETC.

As part of the deal, Evitrade will acquire all outstanding shares of HETC in exchange for 23,333,333 Evitrade shares, priced at 30 Canadian cents apiece.

The closing of the deal is subject to Evitrade completing due diligence with HETC. Following the completion of the deal Hemp will become a wholly owned subsidiary of Evitrade.

Evitrade's CEO C.K. Cheung said that HETC's extraction technology and expertise will help deliver medical grade ingredients for the company's health technology developments. HETC is engaged in extracting medical-grade oils from industrial hemp.

Canada-based Evitrade is a technology company specializing in the life sciences sector and is focused on four main areas — autonomous medical care, molecular biology, nutraceutical solutions and genetic selection.